Only one study has looked at Omicron infections in SARS-CoV-2-vaccinated individuals, and it found anti-SARS-CoV-2 nasal IgA against both the wild-type and the Omicron variant within 28 days after infection [19,20]. This evidence concerns the gene CD79A and infection.